Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533631 · ClinicalTrials.gov registry record
Measuring Brain Health Using Low-Field Portable MRI
A clinical trial of White Matter Hyperintensity, sponsored by Yale University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06533631 is a study of White Matter Hyperintensity that is actively recruiting participants, run by Yale University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06533631, a study of White Matter Hyperintensity, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a new grading scale and utilize automated segmentation for measurement of White Matter Hyperintensity (WMH) volume using a low field MRI.
Conditions Studied
Interventions
- DEVICE Portable low-field MRI (pMRI)
- DEVICE 3T MRI
Study Locations (1)
Connecticut
- Yale Magnetic Resonance Research Center (MRRC) at The Analyn Center (TAC) - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06533631
The ClinicalTrials.gov registry entry for NCT06533631 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with White Matter Hyperintensity appearing as the primary indexed condition, and to 2 interventions - of which Portable low-field MRI (pMRI) is the first listed.
NCT06533631 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06533631 about?
NCT06533631 is a clinical study titled "Measuring Brain Health Using Low-Field Portable MRI". The purpose of this study is to develop a new grading scale and utilize automated segmentation for measurement of White Matter Hyperintensity (WMH) volume using a low field MRI.
What is the current status of trial NCT06533631?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-02-05. Estimated completion is 2026-11.
What conditions does trial NCT06533631 study?
This clinical trial studies the following conditions: White Matter Hyperintensity.
What interventions are being tested in trial NCT06533631?
The interventions under investigation include: Portable low-field MRI (pMRI) (DEVICE), 3T MRI (DEVICE).
Who is sponsoring clinical trial NCT06533631?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06533631 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.